Work

Systemic Bevacizumab (Avastin) Therapy for Neovascular Age-Related Macular DegenerationTwelve-Week Results of an Uncontrolled Open-Label Clinical Study

FWCI: 71.83
Cites: 66
Cited by: 668
Related to: 10